OraSure Sees Profitability In 2002 With OraQuick, UPlink Introductions
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies expects FDA approvals of its UPlink drugs-of-abuse test and OraQuick rapid HIV assay to help the firm reach profitability this year and grow revenues 30% over 2001